http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-217780-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-08
filingDate 1994-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0b34dc9ff2514db23be9b5ef9ffbd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb7c428c36ebc39a0708516bd229433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a220a6af0bcc4acd50917a510f4430
publicationDate 2000-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-217780-B
titleOfInvention Process for catalytic ring closure of 3-methylpiperidine or 3-methylpyridine by 2-methyl-1,5-diaminopentane
abstract The present invention relates to a process for the preparation of 3-methylpiperidine and 3-methylpyridine on the catalytic ring closure of 2-methyl-1,5-diaminopentane. According to the invention, the gaseous 2-methyl-1,5-diaminopentane is passed through a catalyst, which is activated alumina, aluminum silicon oxide, at a pressure of 300-400 ° C (0-10) × 105 Pa without the addition of ammonia. consisting of either natural or synthetic eneolite, having a ratio of acidic and basic centers on the surface of more than 2 and a specific surface area exceeding 40 m2 / g. If desired, 3-methylpiperidine prepared according to the foregoing is further converted, via dehydrogenation catalyst, into 3-methylpyridine. ŕ
priorityDate 1994-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449935281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454699286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71366267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415780649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451911844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18331048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414034709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16686034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422121696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222

Total number of triples: 44.